Creekridge Capital Signs Leasing Program Agreement with Endocare, Inc

Business Wire,  Nov 26, 2007  

• E-mail
• Print
• Link

MINNEAPOLIS -- Creekridge Capital LLC, a nationwide independent healthcare and technology vendor leasing company, has signed an agreement with Endocare, Inc., (NASDAQ:ENDO) to provide leasing programs for the company's minimally-invasive cryoablation technology.

The leasing programs enable Endocare to offer physicians efficient and affordable access to its technology that treats prostate cancer, renal, lung, liver tumors and pain management.

"By offering lease programs, we can better serve our clients with a full-service approach," said Kevin Quilty, senior vice president of Sales and Marketing for Endocare. "We believe that this will be useful as we expand our focus across a number of surgical markets."

Art Greve, senior vice president of Sales, for Creekridge Capital noted, "We're pleased to have developed a leasing program that fits seamlessly into Endocare's strategies to increase market share." The program further expands Creekridge Capital's reach and expertise in the urology market.

Creekridge Capital LLC is a provider of creative leasing solutions with special expertise in developing vendor program partnerships for healthcare and technology companies. Based in Minneapolis, the company has offices throughout the United States. More information is available at www.creekridgecapital.com.

COPYRIGHT 2007 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning